IEX •
Healthcare •
Biotechnology •
Quote as of 06/23/2026 15:59
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeIEX
Market Capitalization1,289.33 mln
Float146 mln
Earnings Date08/18/2026
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
-4.87
Highly reliable
1-Year Forecast
9.61
Strong upside
Relative Strength
92
/ 100
Top performer
Debt / Equity
0.03
Debt-free
ROE
-62.74
Deeply negative
Business Description
Founded in 2011 and based in Vancouver, Washington, Absci Corporation is a clinical-stage company focused on creating antibody-based treatments for conditions such as inflammatory bowel disease, hair loss, and cancer. Several of its drug candidates are currently being tested in human trials, while others remain in earlier stages of research. The company works alongside a number of partners, including Memorial Sloan Kettering Cancer Center, Oracle Corporation, and Advanced Micro Devices, to advance its scientific and development efforts.
